1. Home
  2. FOR vs NEO Comparison

FOR vs NEO Comparison

Compare FOR & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Forestar Group Inc

FOR

Forestar Group Inc

HOLD

Current Price

$27.79

Market Cap

1.4B

Sector

Finance

ML Signal

HOLD

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$10.60

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOR
NEO
Founded
2005
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Precision Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
2007
2008

Fundamental Metrics

Financial Performance
Metric
FOR
NEO
Price
$27.79
$10.60
Analyst Decision
Buy
Strong Buy
Analyst Count
3
8
Target Price
$32.67
$13.38
AVG Volume (30 Days)
121.2K
1.3M
Earning Date
04-21-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.93
N/A
Revenue
$1,662,400,000.00
N/A
Revenue This Year
$0.34
$10.63
Revenue Next Year
$7.73
$9.73
P/E Ratio
$29.49
N/A
Revenue Growth
10.14
N/A
52 Week Low
$18.73
$4.72
52 Week High
$30.74
$13.74

Technical Indicators

Market Signals
Indicator
FOR
NEO
Relative Strength Index (RSI) 58.69 74.64
Support Level $24.22 $9.35
Resistance Level $29.05 $10.66
Average True Range (ATR) 0.84 0.45
MACD 0.12 0.18
Stochastic Oscillator 85.00 95.96

Price Performance

Historical Comparison
FOR
NEO

About FOR Forestar Group Inc

Forestar Group Inc is a residential lot development company engaged in land acquisition and development for the sale of finished single-family residential lots to local, regional, and national homebuilders. The company operates through a single real estate segment, which acquires land, installs infrastructure for residential communities, and generates all revenue from lot sales. Its communities mainly support entry-level, first-time move-up, and active-adult homes, with certain communities also marketed to build-to-rent operators. The company generally invests in entitled, short-duration projects that can be developed in phases to align lot production with market demand and support efficient capital deployment.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: